candesartan and lvv-hemorphin-7

candesartan has been researched along with lvv-hemorphin-7 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ebinger, G; Fournié-Zaluski, MC; Michotte, Y; Sarre, S; Stragier, B; Vanderheyden, P; Vauquelin, G	1

Other Studies

1 other study(ies) available for candesartan and lvv-hemorphin-7

Article	Year
Metabolism of angiotensin II is required for its in vivo effect on dopamine release in the striatum of the rat. Journal of neurochemistry, 2004, Volume: 90, Issue:5 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Chromatography, High Pressure Liquid; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Drug Interactions; Hemoglobins; Imidazoles; Male; Methionine; Microdialysis; Naltrexone; Narcotic Antagonists; Peptide Fragments; Pyridines; Rats; Rats, Wistar; Receptor, Angiotensin, Type 2; Sulfonic Acids; Tetrazoles; Time Factors	2004

Article

Year

Metabolism of angiotensin II is required for its in vivo effect on dopamine release in the striatum of the rat.

Journal of neurochemistry, 2004, Volume: 90, Issue:5

Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Chromatography, High Pressure Liquid; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Drug Interactions; Hemoglobins; Imidazoles; Male; Methionine; Microdialysis; Naltrexone; Narcotic Antagonists; Peptide Fragments; Pyridines; Rats; Rats, Wistar; Receptor, Angiotensin, Type 2; Sulfonic Acids; Tetrazoles; Time Factors

2004